Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Dakin’s Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy

See Locations Near You

Summary

This pilot clinical trial studies Dakin's solution in preventing radiation dermatitis in patients with breast cancer undergoing radiation therapy. Radiation dermatitis is a skin condition in which the affected skin becomes painful, red, itchy, and blistered. Dakin's solution may help reduce dermatitis caused by radiation therapy.

View Full Description

Full Description

PRIMARY OBJECTIVES:

I. To determine the percent change in women who experience grade 3 or 4 radiation dermatitis as defined by the Stanford Radiation Dermatitis Scoring System during radiation treatment for breast cancer compared to historical experience using standard skin care.

SECONDARY OBJECTIVES:

I. To assess the feasibility of daily application of the hypochlorite solution (Dakin's solution), and to assess levels of pain during radiotherapy treatment.

OUTLINE:

Patients apply Dakin's solution topically daily over 10 minutes within 60 minutes of radiation therapy for up to 6 weeks.

After completion of study treatment, patients are followed up at 4-6 weeks.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Women with breast cancer who plan to undergo radiation therapy to the breast or chest wall
Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

Women with scleroderma or discoid lupus
Women with inflammatory breast cancer as evidenced by clinical assessment
Women with breast cancer involving the skin
Women who have undergone prior radiotherapy to the chest wall and/or breast

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

20

Study ID:

NCT02203565

Recruitment Status:

Completed

Sponsor:

Stanford University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Stanford University, School of Medicine
Stanford California, 94305, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

20

Study ID:

NCT02203565

Recruitment Status:

Completed

Sponsor:


Stanford University

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider